MedTrace Logo

Early Community Client-LED ART Delivery in Nakivale Refugee Settlement

NCT04736316 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2023-07-11

Study results available
· View outcomes & findings →

Summary

To pilot early community client-led ART (anti-retroviral therapy) delivery (CCLAD) in Nakivale Refugee Settlement in Uganda and assess the feasibility and acceptability of this intervention in this setting.

Conditions

  • HIV Seropositivity

Interventions

BEHAVIORAL

Early CCLAD

Community-based client led antiretroviral therapy delivery groups.

Sponsors & Collaborators

Principal Investigators

  • Kelli N O'Laughlin, MD, MPH · University of Washington

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-29
Primary Completion
2022-03-31
Completion
2022-03-31

Countries

  • Uganda

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04736316 on ClinicalTrials.gov